MPI Research provides preclinical services to agricultural, environmental, biopharmaceutical, medical device, animal health, and chemical industries. MPI Research has conducted thousands of studies in both small and large molecules in a wide and diverse range of compound classes, through all routes of administration (excluding inhalation) and offers studies with numerous species and models. Our recent achievements warrant a closer look to see how we’ve expanded to integrate the full spectrum of services for new drug and device candidates. MPI Research also has a focus on efficacy testing and has a strong presence within the cellular and molecular biology fields, biomarkers, and gene therapy. With ample physical and technical capacity, we can accommodate multiple requirements simultaneously, adjust schedules readily, and produce results quickly. MPI Research Study Directors and Scientists are uniquely accessible on a real-time basis and are diligent at keeping Sponsors informed as developments unfold, from collaboration on the initial program design through final report. Taking you further. Explore more at www.mpiresearch.com.
Looking for a particular MPI Research employee's phone or email?
The MPI Research annual revenue was $320 million in 2026.
Monte Reimers is the Director, Regional Business Development of MPI Research.
264 people are employed at MPI Research.
MPI Research is based in Mattawan, Michigan.
The NAICS codes for MPI Research are [5418, 541, 54].
The SIC codes for MPI Research are [372, 37].